Tag: life sciences
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
MD Anderson, Broad Institute Partner on Rare Cancers
MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Moderna Supplying 500M Vaccine Doses to Covax
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries.
-
Multiple Organs Impaired in Long Covid-19 Patients
A study of individuals with lingering symptoms from Covid-19 shows they experience impaired organ functions months after the initial infections.